PhD defence: Lene Munk
The effect of reduced exposure time of a known intravesical treatment to minimize side effects and increase the feasibility of scheduled instillations
Info about event
Time
Location
The Auditorium, Department of Molecular Medicine (MOMA), level 2, Brendstrupgårdsvej 21A, 8200 Aarhus N
On Thursday 15 May at 14:00, Lene Munk defends her PhD dissertation entitled "The NORTH-REG Dwell Time study; Effect of reduced BCG dwell time on side effects and completion rates - A multinational randomised controlled trial".
Non-muscle invasive bladder cancer is a disease in which patients frequently experience recurrence. To reduce the risk of recurrence, intravesical treatment is administered following surgery. BCG is a commonly used intravesical therapy, but unfortunately, the majority of patients experience side effects and discontinue treatment prematurely. To improve this treatment, we investigated whether reducing the time the instillation remains in the bladder could reduce side effects and increase the number of patients able to complete all planned treatments.
The study was designed as a randomized controlled trial, comparing standard dwell time with a reduced dwell time in patients experiencing a certain severity of side effects.
The summary is written by the PhD student.
The defence is public and takes place in the Auditorium, Department of Molecular Medicine (MOMA), level 2, Brendstrupgårdsvej 21A, 8200 Aarhus N. Please see the press release for more information.
Contact
PhD student Lene Munk
Mail: lenemu@rm.dk
Phone: (+45) 20459332